Last year Distillations talked to people who have special insight into the coronavirus crisis (../../../distillations/pandemic-perspectives) —biomedical researchers, physicians, public health experts, and historians. In this episode we talk to Stéphane Bancel, CEO of Moderna, a biotech company that developed one of the three emergency-approved COVID-19 vaccines in the United States. The Moderna vaccine is unique in that it uses a new technology that has been decades in the making called messenger RNA, or mRNA. Bancel reflects on the development timeline of the vaccine: from learning about the virus while reading the Wall Street Journal in 2019 to the moment he finally got his own shot at a Moderna facility. He talks about the promise of mRNA and what’s ahead for Moderna.
Credits
Host: Alexis Pedrick ([ Ссылка ]) Senior Producer: Mariel Carr (../../../profile/mariel-carr) Producer: Rigoberto Hernandez (../../../profile/rigoberto-hernandez) Researcher: Jessica Wade (../../../profile/jessica-wade) Audio Engineer: Jonathan Pfeffer ([ Ссылка ])
